 |
PDBsum entry 1c2f
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1c2f
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.4
- trypsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
391:608-612
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design of potent selective zinc-mediated serine protease inhibitors.
|
|
B.A.Katz,
J.M.Clark,
J.S.Finer-Moore,
T.E.Jenkins,
C.R.Johnson,
M.J.Ross,
C.Luong,
W.R.Moore,
R.M.Stroud.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Many serine proteases are targets for therapeutic intervention because they
often play key roles in disease. Small molecule inhibitors of serine proteases
with high affinity are especially interesting as they could be used as scaffolds
from which to develop drugs selective for protease targets. One such inhibitor
is bis(5-amidino-2-benzimidazolyl)methane (BABIM), standing out as the best
inhibitor of trypsin (by a factor of over 100) in a series of over 60 relatively
closely related analogues. By probing the structural basis of inhibition, we
discovered, using crystallographic methods, a new mode of high-affinity binding
in which a Zn2+ ion is tetrahedrally coordinated between two chelating nitrogens
of BABIM and two active site residues, His57 and Ser 195. Zn2+, at
subphysiological levels, enhances inhibition by over 10(3)-fold. The distinct
Zn2+ coordination geometry implies a strong dependence of affinity on
substituents. This unique structural paradigm has enabled development of potent,
highly selective, Zn2+-dependent inhibitors of several therapeutically important
serine proteases, using a physiologically ubiquitous metal ion.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 (2|F[o]| - |F[c]|), [c]
map superimposed on the structure of trypsin-keto-BABIM-Zn2+, pH
8.2.
|
 |
Figure 2.
Figure 2 Superposition of trypsin-BABIM-Zn2+ onto
keto-BABIM-Zn2+. In the trypsin-BABIM-Zn2+ structure, carbons
are green, oxygens red, nitrogens blue and sulphurs yellow. In
the trypsin-keto-BABIM-Zn2+ structure, carbons are light blue,
oxygens orange, nitrogens rose, and sulphurs yellow.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(1998,
391,
608-612)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.C.Chai,
and
Q.Z.Ye
(2009).
Metal-mediated inhibition is a viable approach for inhibiting cellular methionine aminopeptidase.
|
| |
Bioorg Med Chem Lett,
19,
6862-6864.
|
 |
|
|
|
|
 |
A.K.Satheesh Babu,
M.A.Vijayalakshmi,
G.J.Smith,
and
K.C.Chadha
(2008).
Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.
|
| |
J Chromatogr B Analyt Technol Biomed Life Sci,
861,
227-235.
|
 |
|
|
|
|
 |
I.Reulecke,
G.Lange,
J.Albrecht,
R.Klein,
and
M.Rarey
(2008).
Towards an integrated description of hydrogen bonding and dehydration: decreasing false positives in virtual screening with the HYDE scoring function.
|
| |
ChemMedChem,
3,
885-897.
|
 |
|
|
|
|
 |
A.Di Fenza,
A.Heine,
U.Koert,
and
G.Klebe
(2007).
Understanding Binding Selectivity toward Trypsin and Factor Xa: the Role of Aromatic Interactions.
|
| |
ChemMedChem,
2,
297-308.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.H.Caughey
(2007).
Mast cell tryptases and chymases in inflammation and host defense.
|
| |
Immunol Rev,
217,
141-154.
|
 |
|
|
|
|
 |
M.Sherawat,
P.Kaur,
M.Perbandt,
C.Betzel,
W.A.Slusarchyk,
G.S.Bisacchi,
C.Chang,
B.L.Jacobson,
H.M.Einspahr,
and
T.P.Singh
(2007).
Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr,
63,
500-507.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.E.Boldt,
J.P.Kennedy,
M.S.Hixon,
L.A.McAllister,
J.T.Barbieri,
S.Tzipori,
and
K.D.Janda
(2006).
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.
|
| |
J Comb Chem,
8,
513-521.
|
 |
|
|
|
|
 |
J.Hallgren,
and
G.Pejler
(2006).
Biology of mast cell tryptase. An inflammatory mediator.
|
| |
FEBS J,
273,
1871-1895.
|
 |
|
|
|
|
 |
B.S.Sandanaraj,
D.R.Vutukuri,
J.M.Simard,
A.Klaikherd,
R.Hong,
V.M.Rotello,
and
S.Thayumanavan
(2005).
Noncovalent modification of chymotrypsin surface using an amphiphilic polymer scaffold: implications in modulating protein function.
|
| |
J Am Chem Soc,
127,
10693-10698.
|
 |
|
|
|
|
 |
R.Paulini,
K.Müller,
and
F.Diederich
(2005).
Orthogonal multipolar interactions in structural chemistry and biology.
|
| |
Angew Chem Int Ed Engl,
44,
1788-1805.
|
 |
|
|
|
|
 |
R.Schiffmann,
A.Heine,
G.Klebe,
and
C.D.Klein
(2005).
Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: a critical view of the relevance of in vitro metalloenzyme assays.
|
| |
Angew Chem Int Ed Engl,
44,
3620-3623.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Kontogiorgis,
and
D.Hadjipavlou-Litina
(2004).
Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
|
| |
Med Res Rev,
24,
687-747.
|
 |
|
|
|
|
 |
H.K.Leiros,
B.O.Brandsdal,
O.A.Andersen,
V.Os,
I.Leiros,
R.Helland,
J.Otlewski,
N.P.Willassen,
and
A.O.Smalås
(2004).
Trypsin specificity as elucidated by LIE calculations, X-ray structures, and association constant measurements.
|
| |
Protein Sci,
13,
1056-1070.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.M.Barros,
I.L.Tersariol,
M.L.Oliva,
M.S.Araújo,
C.A.Sampaio,
L.Juliano,
and
G.da Motta
(2004).
High molecular weight kininogen as substrate for cathepsin B.
|
| |
Biol Chem,
385,
551-555.
|
 |
|
|
|
|
 |
E.Toyota,
H.Sekizaki,
K.Itoh,
and
K.Tanizawa
(2003).
Synthesis and evaluation of guanidine-containing Schiff base copper(II), zinc(II), and iron(III) chelates as trypsin inhibitors.
|
| |
Chem Pharm Bull (Tokyo),
51,
625-629.
|
 |
|
|
|
|
 |
J.A.Krauser,
J.Potempa,
J.Travis,
and
J.C.Powers
(2002).
Inhibition of arginine gingipains (RgpB and HRgpA) with benzamidine inhibitors: zinc increases inhibitory potency.
|
| |
Biol Chem,
383,
1193-1198.
|
 |
|
|
|
|
 |
S.Eswaramoorthy,
D.Kumaran,
and
S.Swaminathan
(2002).
A novel mechanism for Clostridium botulinum neurotoxin inhibition.
|
| |
Biochemistry,
41,
9795-9802.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Nguyen,
and
I.Huc
(2001).
Using an Enzyme's Active Site To Template Inhibitors This work was supported by the Centre National de la Recherche Scientifique and by the Ecole Polytechnique (predoctoral fellowship to R.N.). We thank Prof. Jean-Marie Lehn for stimulating discussions.
|
| |
Angew Chem Int Ed Engl,
40,
1774-1776.
|
 |
|
|
|
|
 |
S.Valente,
M.Gobbo,
G.Licini,
A.Scarso,
and
P.Scrimin
(2001).
Allosteric Regulation of an HIV-1 Protease Inhibitor by Zn(II) Ions This work was funded by MURST (COFIN2000-MM03194891). We thank Prof. P. Tecilla (U. Trieste) for valuable comments.
|
| |
Angew Chem Int Ed Engl,
40,
3899-3902.
|
 |
|
|
|
|
 |
D.R.Abendschein,
P.K.Baum,
D.J.Martin,
R.Vergona,
J.Post,
G.Rumennik,
M.E.Sullivan,
P.R.Eisenberg,
and
D.R.Light
(2000).
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
|
| |
J Cardiovasc Pharmacol,
35,
796-805.
|
 |
|
|
|
|
 |
J.W.Janc,
J.M.Clark,
R.L.Warne,
K.C.Elrod,
B.A.Katz,
and
W.R.Moore
(2000).
A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II).
|
| |
Biochemistry,
39,
4792-4800.
|
 |
|
|
|
|
 |
N.A.Meanwell,
and
M.Krystal
(2000).
Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents.
|
| |
Drug Discov Today,
5,
241-252.
|
 |
|
|
|
|
 |
P.Wu,
J.Leinonen,
E.Koivunen,
H.Lankinen,
and
U.H.Stenman
(2000).
Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity.
|
| |
Eur J Biochem,
267,
6212-6220.
|
 |
|
|
|
|
 |
C.E.Elling,
K.Thirstrup,
B.Holst,
and
T.W.Schwartz
(1999).
Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor.
|
| |
Proc Natl Acad Sci U S A,
96,
12322-12327.
|
 |
|
|
|
|
 |
C.P.Sommerhoff,
W.Bode,
P.J.Pereira,
M.T.Stubbs,
J.Stürzebecher,
G.P.Piechottka,
G.Matschiner,
and
A.Bergner
(1999).
The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.
|
| |
Proc Natl Acad Sci U S A,
96,
10984-10991.
|
 |
|
|
|
|
 |
I.D.Kuntz,
K.Chen,
K.A.Sharp,
and
P.A.Kollman
(1999).
The maximal affinity of ligands.
|
| |
Proc Natl Acad Sci U S A,
96,
9997.
|
 |
|
|
|
|
 |
M.L.López-Rodríguez,
A.Viso,
B.Benhamú,
J.L.Rominguera,
and
M.Murcia
(1999).
Synthesis of new (benzimidazolyl)piperazines with affinity for the 5-HT1A receptor via Pd(0) amination of bromobenzimidazoles.
|
| |
Bioorg Med Chem Lett,
9,
2339-2342.
|
 |
|
|
|
|
 |
B.A.Katz,
B.Liu,
M.Barnes,
and
E.B.Springman
(1998).
Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
|
| |
Protein Sci,
7,
875-885.
|
 |
|
|
|
|
 |
H.H.Thorp
(1998).
Bioinorganic chemistry and drug design: here comes zinc again.
|
| |
Chem Biol,
5,
R125-R127.
|
 |
|
|
|
|
 |
S.R.Presnell,
G.S.Patil,
C.Mura,
K.M.Jude,
J.M.Conley,
J.A.Bertrand,
C.M.Kam,
J.C.Powers,
and
L.D.Williams
(1998).
Oxyanion-mediated inhibition of serine proteases.
|
| |
Biochemistry,
37,
17068-17081.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |